Skip to Content

8,986 Results Found

  • Review
  • Open Access
38 Citations
8,179 Views
20 Pages

Retinoid X Receptor Antagonists

  • Masaki Watanabe and
  • Hiroki Kakuta

Retinoid X receptor (RXR) antagonists are not only useful as chemical tools for biological research, but are also candidate drugs for the treatment of various diseases, including diabetes and allergies, although no RXR antagonist has yet been approve...

  • Article
  • Open Access
5 Citations
3,076 Views
22 Pages

Synthesis of Hydantoin Androgen Receptor Antagonists and Study on Their Antagonistic Activity

  • Longjun Ma,
  • Yan Zhou,
  • Dehua Yang,
  • Ming-Wei Wang,
  • Wei Lu and
  • Jiyu Jin

10 September 2022

Hydroxymethylthiohydantoin, hydroxymethylthiohydantoin, and hydantoin, containing a pyridine group, were synthesized to study their androgen receptor antagonistic activities. Among them, compounds 6a/6c/7g/19a/19b exhibited excellent androgen recepto...

  • Review
  • Open Access
30 Citations
6,642 Views
33 Pages

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists

  • Berthold A. Nock,
  • Panagiotis Kanellopoulos,
  • Lieke Joosten,
  • Rosalba Mansi and
  • Theodosia Maina

30 April 2023

The clinical success of radiolabeled somatostatin analogs in the diagnosis and therapy—“theranostics”—of tumors expressing the somatostatin subtype 2 receptor (SST2R) has paved the way for the development of a broader panel of...

  • Review
  • Open Access
49 Citations
17,825 Views
20 Pages

NMDA Receptor Antagonists for Treatment of Depression

  • Zeynep Ates-Alagoz and
  • Adeboye Adejare

3 April 2013

Depression is a psychiatric disorder that affects millions of people worldwide. Individuals battling this disorder commonly experience high rates of relapse, persistent residual symptoms, functional impairment, and diminished well-being. Medications...

  • Review
  • Open Access
42 Citations
9,703 Views
25 Pages

Recent Development of Non-Peptide GnRH Antagonists

  • Feng-Ling Tukun,
  • Dag Erlend Olberg,
  • Patrick J. Riss,
  • Ira Haraldsen,
  • Anita Kaass and
  • Jo Klaveness

9 December 2017

The decapeptide gonadotropin-releasing hormone, also referred to as luteinizing hormone-releasing hormone with the sequence (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) plays an important role in regulating the reproductive system. It stimulates di...

  • Review
  • Open Access
35 Citations
10,371 Views
25 Pages

The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers

  • Mallory Batty,
  • Rachel Pugh,
  • Ilampirai Rathinam,
  • Joshua Simmonds,
  • Edwin Walker,
  • Amanda Forbes,
  • Shailendra Anoopkumar-Dukie,
  • Catherine M. McDermott,
  • Briohny Spencer and
  • Russ Chess-Williams
  • + 1 author

This review evaluates the role of α-adrenoceptor antagonists as a potential treatment of prostate cancer (PCa). Cochrane, Google Scholar and Pubmed were accessed to retrieve sixty-two articles for analysis. In vitro studies demonstrate that doxazosin...

  • Article
  • Open Access
6 Citations
3,634 Views
19 Pages

21 March 2021

Several years ago, the crystallographic structures of the transient receptor potential vanilloid 1 (TRPV1) in the presence of agonists and antagonists were reported, providing structural information about its chemical activation and inactivation. TRP...

  • Review
  • Open Access
9 Citations
8,005 Views
16 Pages

Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases

  • Rachid Mahmoudi,
  • Jean Luc Novella,
  • Sarah Laurent-Badr,
  • Sarah Boulahrouz,
  • David Tran,
  • Isabella Morrone and
  • Yacine Jaïdi

Cholinergic antagonists interfere with synaptic transmission in the central nervous system and are involved in pathological processes in patients with neurocognitive disorders (NCD), such as behavioral and psychological symptoms of dementia (BPSD). I...

  • Article
  • Open Access
2 Citations
2,647 Views
14 Pages

Antagonists Enhance Cell-Surface Expression of Mammalian Odorant Receptors

  • Ikumi Takayama,
  • Nako Araki,
  • Jeevan Tewari,
  • Masafumi Yohda,
  • Hiroaki Matsunami and
  • Yosuke Fukutani

10 February 2025

Functional characterization of vertebrate odorant receptors (ORs), members of the G protein-coupled receptor (GPCR) family, is essential for understanding olfaction. However, the functional expression of ORs in heterologous cells is often challenging...

  • Review
  • Open Access
20 Citations
20,768 Views
13 Pages

COVID-19 has rapidly become a pandemic worldwide, causing extensive and long-term health issues. There is an urgent need to identify therapies that limit SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Unbalanced lung inflammation...

  • Review
  • Open Access
52 Citations
15,452 Views
18 Pages

Endothelin Receptor Antagonists in Kidney Disease

  • Irene Martínez-Díaz,
  • Nerea Martos,
  • Carmen Llorens-Cebrià,
  • Francisco J. Álvarez,
  • Patricia W. Bedard,
  • Ander Vergara,
  • Conxita Jacobs-Cachá and
  • Maria José Soler

8 February 2023

Endothelin (ET) is found to be increased in kidney disease secondary to hyperglycaemia, hypertension, acidosis, and the presence of insulin or proinflammatory cytokines. In this context, ET, via the endothelin receptor type A (ETA) activation, causes...

  • Article
  • Open Access
9 Citations
4,180 Views
18 Pages

25 July 2019

Fusarium species coexist as toxigenic, systemic pathogens in sweet corn seed production in southwestern Idaho, USA. We hypothesized that fungal antagonists of seedborne Fusarium would differentially alter production of Fusarium mycotoxins directly an...

  • Article
  • Open Access
36 Citations
5,903 Views
13 Pages

Wear Behavior of Ceramic CAD/CAM Crowns and Natural Antagonists

  • Ella A. Naumova,
  • Stephan Schneider,
  • Wolfgang H. Arnold and
  • Andree Piwowarczyk

28 February 2017

Objective: Evaluation of wear behavior of computer-aided design/computer-aided manufacturing (CAD/CAM) crowns from various restorative materials and natural antagonists. Method: Full CAD/CAM crowns fabricated with nanoceramic resin (Lava Ultimate (LU...

  • Perspective
  • Open Access
8 Citations
4,550 Views
11 Pages

Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer

  • Meredith Mihalopoulos,
  • Zachary Dovey,
  • Maddison Archer,
  • Talia G. Korn,
  • Kennedy E. Okhawere,
  • William Nkemdirim,
  • Hassan Funchess,
  • Ami Rambhia,
  • Nihal Mohamed and
  • Natasha Kyprianou
  • + 5 authors

28 August 2020

Renal cancer ranks twelfth in incidence among cancers worldwide. Despite improving outcomes due to better therapeutic options and strategies, prognosis for those with metastatic disease remains poor. Current systemic therapeutic approaches include in...

  • Article
  • Open Access
11 Citations
3,521 Views
15 Pages

Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists

  • Johanna Bödder,
  • Leanne M. Kok,
  • Jonathan A. Fauerbach,
  • Georgina Flórez-Grau and
  • I. Jolanda M. de Vries

11 January 2023

Prostaglandin E2 (PGE2) is an important maturation mediator for dendritic cells (DCs). However, increased PGE2 levels in the tumor exert immunosuppressive effects on DCs by signaling through two E-Prostanoid (EP) receptors: EP2 and EP4. Blocking EP-r...

  • Article
  • Open Access
2 Citations
2,857 Views
26 Pages

Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists

  • Amélie Laversin,
  • Robin Dufossez,
  • Raphaël Bolteau,
  • Romain Duroux,
  • Séverine Ravez,
  • Sergio Hernandez-Tapia,
  • Martin Fossart,
  • Mathilde Coevoet,
  • Maxime Liberelle and
  • Patricia Melnyk
  • + 2 authors

14 August 2024

The adenosine A2A receptor (A2AR) has been identified as a therapeutic target for treating neurodegenerative diseases and cancer. In recent years, we have highlighted the 2-aminoquinazoline heterocycle as an promising scaffold for designing new A2AR...

  • Review
  • Open Access
26 Citations
9,284 Views
16 Pages

The bone morphogenetic proteins (BMPs), a subgroup of the transforming growth factor-β (TGF-β) superfamily, are involved in multiple biological processes such as embryonic development and maintenance of adult tissue homeostasis. The importa...

  • Review
  • Open Access
74 Citations
22,962 Views
25 Pages

Voltage-Gated Calcium Channel Antagonists and Traumatic Brain Injury

  • Gene Gurkoff,
  • Kiarash Shahlaie,
  • Bruce Lyeth and
  • Robert Berman

26 June 2013

Traumatic brain injury (TBI) is a leading cause of death and disability in the United States. Despite more than 30 years of research, no pharmacological agents have been identified that improve neurological function following TBI. However, several li...

  • Article
  • Open Access
14 Citations
4,198 Views
19 Pages

Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation

  • Gabriella Marucci,
  • Diego Dal Ben,
  • Catia Lambertucci,
  • Aleix Martí Navia,
  • Andrea Spinaci,
  • Rosaria Volpini and
  • Michela Buccioni

23 February 2021

Alzheimer’s, Parkinson’s, and multiple sclerosis are neurodegenerative diseases related by neuronal degeneration and death in specific areas of the central nervous system. These pathologies are associated with neuroinflammation, which is involved in...

  • Communication
  • Open Access
13 Citations
5,033 Views
9 Pages

Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors

  • Bahareh Rasaeifar,
  • Patricia Gomez-Gutierrez and
  • Juan J. Perez

21 September 2020

Angiotensin converting enzyme 2 (ACE2) downregulation is a key negative factor for the severity of lung edema and acute lung failure observed in patients infected with SARS-CoV-2. ACE2 downregulation affects the levels of diverse peptide mediators of...

  • Article
  • Open Access
8 Citations
4,123 Views
10 Pages

The Universal 3D QSAR Model for Dopamine D2 Receptor Antagonists

  • Agata Zięba,
  • Justyna Żuk,
  • Damian Bartuzi,
  • Dariusz Matosiuk,
  • Antti Poso and
  • Agnieszka A. Kaczor

14 September 2019

In order to search for novel antipsychotics acting through the D2 receptor, it is necessary to know the structure–activity relationships for dopamine D2 receptor antagonists. In this context, we constructed the universal three-dimensional quant...

  • Article
  • Open Access
10 Citations
4,447 Views
21 Pages

Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists

  • Leila Mousavifar,
  • Meysam Sarshar,
  • Clarisse Bridot,
  • Daniela Scribano,
  • Cecilia Ambrosi,
  • Anna Teresa Palamara,
  • Gérard Vergoten,
  • Benoît Roubinet,
  • Ludovic Landemarre and
  • René Roy
  • + 1 author

Selective antiadhesion antagonists of Uropathogenic Escherichia coli (UPEC) type-1 Fimbrial adhesin (FimH) are attractive alternatives for antibiotic therapies and prophylaxes against acute or recurrent urinary tract infections (UTIs) caused by UPECs...

  • Article
  • Open Access
4 Citations
3,678 Views
21 Pages

Novel 1,4-Dihydropyridine Derivatives as Mineralocorticoid Receptor Antagonists

  • Felipe Luis Pérez-Gordillo,
  • Natalia Serrano-Morillas,
  • Luz Marina Acosta-García,
  • María Teresa Aranda,
  • Daniela Passeri,
  • Roberto Pellicciari,
  • María Jesús Pérez de Vega,
  • Rosario González-Muñiz,
  • Diego Alvarez de la Rosa and
  • Mercedes Martín-Martínez

26 January 2023

The mineralocorticoid receptor (MR) belongs to the steroid receptor subfamily of nuclear receptors. MR is a transcription factor key in regulating blood pressure and mineral homeostasis. In addition, it plays an important role in a broad range of bio...

  • Review
  • Open Access
22 Citations
9,440 Views
19 Pages

Recent Advances on Small-Molecule Antagonists Targeting TLR7

  • Haoyang Zheng,
  • Peiyang Wu and
  • Pierre-Antoine Bonnet

7 January 2023

Toll-like receptor 7 (TLR7) is a class of pattern recognition receptors (PRRs) recognizing the pathogen-associated elements and damage and as such is a major player in the innate immune system. TLR7 triggers the release of pro-inflammatory cytokines...

  • Article
  • Open Access
11 Citations
5,378 Views
13 Pages

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists

  • Parthasaradhireddy Tanguturi,
  • Vibha Pathak,
  • Sixue Zhang,
  • Omar Moukha-Chafiq,
  • Corinne E. Augelli-Szafran and
  • John M. Streicher

5 November 2021

The delta opioid receptor (DOR) is a crucial receptor system that regulates pain, mood, anxiety, and similar mental states. DOR agonists, such as SNC80, and DOR-neutral antagonists, such as naltrindole, were developed to investigate the DOR in vivo a...

  • Article
  • Open Access
12 Citations
5,539 Views
19 Pages

TRPA1 is a transmembrane cation channel, one of the most promising targets in the context of respiratory diseases. Its general structure has already been experimentally resolved, but the binding site of TRPA1 antagonists such as HC-030031, a model me...

  • Proceeding Paper
  • Open Access
2,273 Views
4 Pages

Calmodulin Antagonists as Potential Therapeutic Agents for Cancer Treatment “Breast Cancer”

  • Falah A. M. Salih,
  • Ahmad Zaidi Tani,
  • Vijay Kumar,
  • Janan Hadi and
  • David Mutanjun

6 December 2018

Although cancer research undergone a rapid expansion, there is no potential cure and the disease remains one of the leading causes of mortality worldwide. Breast cancer continues as the female malignancy and a major cause of death in middle-aged wome...

  • Article
  • Open Access
7 Citations
3,313 Views
11 Pages

11 March 2022

The function of the allosteric sodium ion in stabilizing the inactive form of GPCRs has been extensively described in the past decades. Its presence has been reported to be essential for the binding of antagonist molecules in the orthosteric site of...

  • Review
  • Open Access
26 Citations
9,750 Views
33 Pages

18 January 2023

Since the 1990s, ionotropic glutamate receptors have served as an outstanding target for drug discovery research aimed at the discovery of new neurotherapeutic agents. With the recent approval of perampanel, the first marketed non-competitive antagon...

  • Review
  • Open Access
24 Citations
5,879 Views
15 Pages

Numerous studies have demonstrated the antidepressant effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists in various rodent models. Importantly, it has been shown that the antidepressant effects of mGlu2/3 receptor antagonists i...

  • Article
  • Open Access
7 Citations
22,376 Views
12 Pages

15 November 2006

Multiple linear regression analysis was performed on the quantitative structure-activity relationships (QSAR) of the triazoloquinazoline adenosine antagonists for human A3receptors. The data set used for the QSAR analysis encompassed the activities o...

  • Article
  • Open Access
2 Citations
1,894 Views
13 Pages

In Silico Investigation of Mineralocorticoid Receptor Antagonists: Insights into Binding Mechanisms and Structural Dynamics

  • Julia J. Liang,
  • Sara Cao,
  • Andrew Hung,
  • Assam El-Osta,
  • Tom C. Karagiannis and
  • Morag J. Young

The mineralocorticoid receptor (MR) is a steroid hormone receptor that plays a key role in regulating sodium and water homeostasis and blood pressure. MR antagonists are a guideline recommended for therapy for the treatment of hypertension and cardio...

  • Review
  • Open Access
16 Citations
8,631 Views
25 Pages

Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis

  • Nariman Essmat,
  • Dávid Árpád Karádi,
  • Ferenc Zádor,
  • Kornél Király,
  • Susanna Fürst and
  • Mahmoud Al-Khrasani

24 November 2023

Opioid receptor agonists, particularly those that activate µ-opioid receptors (MORs), are essential analgesic agents for acute or chronic mild to severe pain treatment. However, their use has raised concerns including, among others, intestinal...

  • Review
  • Open Access
40 Citations
12,698 Views
15 Pages

20 October 2021

To evaluate the effectiveness of a new class of medical drugs, namely oral gonadotropin-releasing hormone (GnRH) antagonists, in the management of premenopausal women with endometriosis-associated pelvic pain. We reviewed the most relevant papers (n...

  • Article
  • Open Access
2 Citations
3,597 Views
28 Pages

Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2

  • Max Van Hoof,
  • Sandra Claes,
  • Katrijn Boon,
  • Tom Van Loy,
  • Dominique Schols,
  • Wim Dehaen and
  • Steven De Jonghe

23 February 2023

Upregulated CXCR2 signalling is found in numerous inflammatory, autoimmune and neurodegenerative diseases, as well as in cancer. Consequently, CXCR2 antagonism is a promising therapeutic strategy for treatment of these disorders. We previously identi...

  • Article
  • Open Access
16 Citations
7,259 Views
11 Pages

30 August 2019

THP-1 cells express high levels of native functional nucleotide-binding oligomerization domain 1 (NOD1), NOD2, and Toll-like receptor 4 (TLR4) receptors, and have often been used for investigating the immunomodulatory effects of small molecules. We p...

  • Communication
  • Open Access
5 Citations
6,871 Views
12 Pages

Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists

  • Nuno A. L. Pereira,
  • Francesc X. Sureda,
  • Maria Pérez,
  • Mercedes Amat and
  • Maria M. M. Santos

6 August 2016

Enantiopure tryptophanol is easily obtained from the reduction of its parent natural amino acid trypthophan (available from the chiral pool), and can be used as chiral auxiliary/inductor to control the stereochemical course of a diastereoselective re...

  • Article
  • Open Access
14 Citations
6,413 Views
25 Pages

Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain

  • Nayeon Do,
  • Dongxu Zuo,
  • Miri Kim,
  • Minseok Kim,
  • Hee-Jin Ha,
  • Peter M. Blumberg,
  • Jihyae Ann,
  • Sun Wook Hwang and
  • Jeewoo Lee

13 September 2024

Pain management remains a major challenge in medicine, highlighting the need for the development of new therapeutic agents. The transient receptor potential ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1) are ion channels that play key roles in pain percep...

  • Article
  • Open Access
2 Citations
1,664 Views
15 Pages

A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease

  • Andrea Spinaci,
  • Michela Buccioni,
  • Diego Dal Ben,
  • Beatrice Francucci,
  • Karl-Norbert Klotz,
  • Gabriella Marucci,
  • Nicola Simola,
  • Micaela Morelli,
  • Annalisa Pinna and
  • Catia Lambertucci
  • + 1 author

26 February 2025

Parkinson’s disease (PD) represents a growing challenge to global health, as it involves millions of people. The high grade of disability is due to the loss of dopaminergic neuron activity, and levodopa is the gold-standard therapy used to rest...

  • Review
  • Open Access
19 Citations
19,048 Views
18 Pages

Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?

  • Anna Maria Rzewuska,
  • Monika Żybowska,
  • Ilona Sajkiewicz,
  • Izabela Spiechowicz,
  • Klaudia Żak,
  • Monika Abramiuk,
  • Krzysztof Kułak and
  • Rafał Tarkowski

28 January 2023

Endometriosis is a chronic disease, in which endometrial-like tissue is found outside the uterine cavity. Lesions are typically located in the true pelvis but can be found, in addition to extragenital endometriosis, in the respiratory system, the dia...

  • Feature Paper
  • Review
  • Open Access
27 Citations
7,334 Views
17 Pages

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

  • Nina Vodošek Hojs,
  • Sebastjan Bevc,
  • Robert Ekart,
  • Nejc Piko,
  • Tadej Petreski and
  • Radovan Hojs

Diabetes mellitus is a global health issue and main cause of chronic kidney disease. Both diseases are also linked through high cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) is present in up to 40% of diabetic patients; theref...

  • Review
  • Open Access
226 Citations
19,163 Views
15 Pages

Biocontrol of Postharvest Fruit Fungal Diseases by Bacterial Antagonists: A Review

  • Saul Carmona-Hernandez,
  • Juan J. Reyes-Pérez,
  • Roberto G. Chiquito-Contreras,
  • Gabriel Rincon-Enriquez,
  • Carlos R. Cerdan-Cabrera and
  • Luis G. Hernandez-Montiel

This review deals with the main mechanisms of action exerted by antagonistic bacteria, such as competition for space and nutrients, suppression via siderophores, hydrolytic enzymes, antibiosis, biofilm formation, and induction of plant resistance. Th...

  • Article
  • Open Access
5 Citations
9,410 Views
25 Pages

Investigation on Quantitative Structure Activity Relationships and Pharmacophore Modeling of a Series of mGluR2 Antagonists

  • Meng-Qi Zhang,
  • Xiao-Le Zhang,
  • Yan Li,
  • Wen-Jia Fan,
  • Yong-Hua Wang,
  • Ming Hao,
  • Shu-Wei Zhang and
  • Chun-Zhi Ai

16 September 2011

MGluR2 is G protein-coupled receptor that is targeted for diseases like anxiety, depression, Parkinson’s disease and schizophrenia. Herein, we report the three-dimensional quantitative structure–activity relationship (3D-QSAR) studies of a series of...

  • Article
  • Open Access
1,930 Views
14 Pages

Functionalized Congeners of 2H-Chromene P2Y6 Receptor Antagonists

  • Paola Oliva,
  • Asmita Pramanik,
  • Young-Hwan Jung,
  • Sarah A. Lewicki,
  • Jamie M. Mwendwa,
  • Jong Hwan Park and
  • Kenneth A. Jacobson

16 August 2024

The P2Y6 receptor (P2Y6R), a Gq-coupled receptor, is a potential drug discovery target for various inflammatory and degenerative conditions. Antagonists have been shown to attenuate colitis, acute lung injury, etc. In the search for competitive antag...

  • Review
  • Open Access
43 Citations
9,653 Views
16 Pages

29 June 2021

Lysophosphatidic acid (LPA) is a bioactive lipid mediator primarily derived from membrane phospholipids. LPA initiates cellular effects upon binding to a family of G protein-coupled receptors, termed LPA receptors (LPAR1 to LPAR6). LPA signaling driv...

  • Article
  • Open Access
21 Citations
8,158 Views
10 Pages

Design and Synthesis of a Series of Pyrido[2,3-d]pyrimidine Derivatives as CCR4 Antagonists

  • Hongwei Gong,
  • Hui Qi,
  • Wei Sun,
  • Yang Zhang,
  • Dan Jiang,
  • Junhai Xiao,
  • Xiaohong Yang,
  • Ying Wang and
  • Song Li

20 August 2012

A series of pyrido[2,3-d]pyrimidine derivatives were designed and synthesized based on known CC chemokine receptor 4 (CCR4) antagonists. The activities of all the newly synthesized compounds were evaluated using a chemotaxis inhibition assay. Compoun...

  • Article
  • Open Access
6 Citations
4,008 Views
16 Pages

A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity

  • Andrea Spinaci,
  • Michela Buccioni,
  • Diego Dal Ben,
  • Federica Maggi,
  • Gabriella Marucci,
  • Beatrice Francucci,
  • Giorgio Santoni,
  • Catia Lambertucci and
  • Rosaria Volpini

28 January 2022

The overexpression of the A3 adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in the search for new A3AR ligands, a series of novel 2,N6-disubstituted adenosines (Ados) was...

  • Review
  • Open Access
19 Citations
6,267 Views
18 Pages

Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role

  • Irina Giralt,
  • Gabriel Gallo-Oller,
  • Natalia Navarro,
  • Patricia Zarzosa,
  • Guillem Pons,
  • Ainara Magdaleno,
  • Miguel F. Segura,
  • José Sánchez de Toledo,
  • Lucas Moreno and
  • Josep Roma
  • + 1 author

18 August 2021

The Wnt signaling pathway regulates crucial aspects such as cell fate determination, cell polarity and organogenesis during embryonic development. Wnt pathway deregulation is a hallmark of several cancers such as lung, gastric and liver cancer, and h...

  • Article
  • Open Access
9 Citations
4,299 Views
16 Pages

Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy

  • Deborah Reynaud,
  • Frederic Sergent,
  • Roland Abi Nahed,
  • Wael Traboulsi,
  • Constance Collet,
  • Christel Marquette,
  • Pascale Hoffmann,
  • Gianfranco Balboni,
  • Qun-Yong Zhou and
  • Nadia Alfaidy
  • + 2 authors

Endocrine gland derived vascular endothelial growth factor (EG-VEGF) is a canonical member of the prokineticin (PROKs) family. It acts via the two G-protein coupled receptors, namely PROKR1 and PROKR2. We have recently demonstrated that EG-VEGF is hi...

  • Article
  • Open Access
14 Citations
7,064 Views
35 Pages

Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation

  • Gonzalo Vera,
  • Carlos F. Lagos,
  • Sebastián Almendras,
  • Dan Hebel,
  • Francisco Flores,
  • Gissella Valle-Corvalán,
  • C. David Pessoa-Mahana,
  • Jaime Mella-Raipán,
  • Rodrigo Montecinos and
  • Gonzalo Recabarren-Gajardo

16 August 2016

Based on a known pharmacophore model for 5-HT6 receptor antagonists, a series of novel extended derivatives of the N-arylsulfonyindole scaffold were designed and identified as a new class of 5-HT6 receptor modulators. Eight of the compounds exhibited...

of 180